PRCTPROCEPT BioRobotics Corp
Surgical & Medical Instruments & Apparatus
- Revenue
- $308M
- 37% YoY
- Operating margin
- -33.7%
- 22% YoY
- EBITDA
- −$97M
- 6.7% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- −$176M net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCFired15% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear—Over 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $34M | $75M | $136M | $224M | $308M | 37% |
| Operating income | −$54M | −$81M | −$109M | −$97M | −$104M | 7.5% |
| Net income | −$60K | −$87K | −$106K | −$91K | −$96K | 4.5% |
| Operating cash flow | −$57M | −$80M | −$108M | −$99M | −$49M | 51% |
| Capex | $592K | $3M | $25M | $4M | $9M | 112% |
| Stock-based comp | $4M | $10M | $19M | $32M | $48M | 50% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $22K · 3
- Net
- −$22K
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 75 | 105 |
| FY2024 | — | — | 192 | 97 |
| FY2023 | — | — | 100 | 87 |
| FY2022 | — | — | 99 | 80 |
| FY2021 | — | — | 60 | 98 |